The prognostic value of peripheral blood lymphocyte subsets in patients with bladder carcinoma treated using neoadjuvant M-VEC chemotherapy


SOYGÜR Y. T., Beduk Y., Baltaci S., YAMAN M. Ö., Tokgoz G.

BJU INTERNATIONAL, vol.84, no.9, pp.1069-1072, 1999 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 84 Issue: 9
  • Publication Date: 1999
  • Doi Number: 10.1046/j.1464-410x.1999.00278.x
  • Journal Name: BJU INTERNATIONAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1069-1072
  • Keywords: bladder carcinoma, peripheral blood lymphocyte subsets, chemotherapy, prognosis, TRANSITIONAL-CELL-CARCINOMA, M-VAC METHOTREXATE, CANCER-PATIENTS, UROLOGIC CANCER, VINBLASTINE, DOXORUBICIN, CISPLATIN, TUMORS
  • Ankara University Affiliated: Yes

Abstract

Objectives To assess the prognostic value of peripheral blood lymphocyte subsets in patients with bladder cancer who were treated with neoadjuvant chemotherapy.